Artia Global Partners LP
Net buyer this quarter
$542M
47
+$43.5M
64.5%
Holdings
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026 | |||||
 ABVX | $68.8M | 12.70% | 0.66% | -14.0% | Q3 2025 |
 INSM | $62.8M | 11.59% | 0.27% | -6.3% | Q4 2023 |
 TRVI | $41.2M | 7.61% | 1.55% | +9.8% | Q2 2025 |
 BTSG | $36.1M | 6.66% | 0.26% | +861.6% | Q3 2025 |
 RVMD | $34.7M | 6.41% | 0.09% | +48.3% | Q3 2024 |
 ARGX | $27.6M | 5.09% | 0.05% | Not reported | Q4 2022 |
 ALKS | $23.5M | 4.34% | 0.27% | New | Q2 2026 |
 TVTX | $19.3M | 3.55% | 0.36% | +379.5% | Q1 2025 |
 AZN | $18.7M | 3.44% | Not reported | +3.2% | Q4 2022 |
 NAMS | $17.1M | 3.15% | 0.43% | Not reported | Q1 2024 |
 DNTH | $15.9M | 2.93% | 0.30% | Not reported | Q3 2025 |
 DGX | $13.8M | 2.55% | 0.06% | +59.6% | Q1 2025 |
 IONS | $11.4M | 2.11% | 0.09% | Not reported | Q2 2024 |
 EYPT | $11M | 2.02% | 0.90% | Not reported | Q4 2023 |
 ALMS | $7.84M | 1.45% | Not reported | -14.3% | Q1 2026 |
 VKTX | $7.05M | 1.30% | 0.15% | Not reported | Q4 2022 |
 CELC | $6.21M | 1.15% | 0.12% | +280.8% | Q4 2025 |
 CYTK | $6.02M | 1.11% | 0.06% | +333.7% | Q4 2023 |
 MRK | $6M | 1.11% | 0.00% | Not reported | Q4 2022 |
 RAPP | $5.77M | 1.07% | 0.29% | Not reported | Q3 2025 |
 JNJ | $5.74M | 1.06% | 0.00% | Not reported | Q1 2026 |
 GH | $5.72M | 1.05% | 0.03% | New | Q2 2026 |
 ABSI | $5.38M | 0.99% | 0.30% | New | Q2 2026 |
 SRRK | $5.3M | 0.98% | 0.08% | Not reported | Q1 2025 |
 SION | $5.27M | 0.97% | 0.27% | Not reported | Q4 2025 |
 ASND | $4.73M | 0.87% | 0.03% | Not reported | Q1 2024 |
 ROIV | $4.59M | 0.85% | 0.02% | Not reported | Q1 2023 |
 PALI | $4.16M | 0.77% | 1.15% | Not reported | Q4 2025 |
 EWTX | $4.01M | 0.74% | 0.09% | +50.8% | Q1 2026 |
 BIIB | $3.98M | 0.74% | 0.01% | Not reported | Q4 2022 |
 XENE | $3.92M | 0.72% | 0.07% | Not reported | Q1 2024 |
 BLTE | $3.85M | 0.71% | 0.06% | Not reported | Q4 2025 |
 MLYS | $3.72M | 0.69% | 0.16% | Not reported | Q2 2025 |
 PROK | $3.69M | 0.68% | Not reported | Not reported | Q4 2025 |
 ELVN | $3.66M | 0.68% | 0.10% | +245.0% | Q4 2024 |
 ORKA | $3.18M | 0.59% | 0.05% | Not reported | Q1 2025 |
 PTGX | $2.81M | 0.52% | 0.04% | +0.1% | Q2 2023 |
 UTHR | $2.71M | 0.50% | 0.01% | Not reported | Q1 2025 |
 DRUG | $2.7M | 0.50% | 0.50% | Not reported | Q4 2025 |
 KNSA | $1.87M | 0.34% | Not reported | Not reported | Q2 2025 |
 CMPX | $839K | 0.15% | 0.21% | New | Q2 2026 |
 PRAX | $837K | 0.15% | 0.01% | Not reported | Q4 2025 |
 KOD | $663K | 0.12% | 0.03% | Not reported | Q4 2025 |
 TENX | $612K | 0.11% | 0.13% | Not reported | Q4 2025 |
| NUVL | $605K | 0.11% | 0.16% | Not reported | Q3 2024 |
 PEPG | $370K | 0.07% | 0.30% | Not reported | Q4 2025 |
 SYRE | $355K | 0.07% | 0.00% | New | Q2 2026 |
| Q1 2026 | |||||
| INSM | $103M | 20.59% | 0.29% | -7.8% | Q4 2023 |
| ABVX | $66.9M | 13.39% | 0.76% | Not reported | Q3 2025 |
 LLY | $35.2M | 7.04% | 0.00% | -24.3% | Q4 2022 |
| TRVI | $24M | 4.81% | 1.57% | Not reported | Q2 2025 |
| ARGX | $21.7M | 4.35% | 0.05% | -54.0% | Q4 2022 |
| AZN | $18.8M | 3.77% | Not reported | Not reported | Q4 2022 |
| NAMS | $16.1M | 3.23% | 0.43% | Not reported | Q1 2024 |
| DNTH | $13.7M | 2.74% | 0.30% | -20.5% | Q3 2025 |
| RVMD | $12.2M | 2.43% | 0.06% | +20.0% | Q3 2024 |
| IONS | $10.8M | 2.17% | 0.09% | Not reported | Q2 2024 |
| EYPT | $9.89M | 1.98% | 0.92% | Not reported | Q4 2023 |
| DGX | $8M | 1.60% | 0.04% | Not reported | Q1 2025 |
| ALMS | $7.16M | 1.43% | Not reported | New | Q1 2026 |
| VKTX | $5.88M | 1.18% | 0.16% | -74.9% | Q4 2022 |
| MRK | $5.62M | 1.12% | 0.00% | Not reported | Q4 2022 |
| TERN | $5.53M | 1.11% | 0.09% | New | Q1 2026 |
| JNJ | $5.52M | 1.11% | 0.00% | New | Q1 2026 |
| SION | $4.8M | 0.96% | 0.27% | Not reported | Q4 2025 |
| SRRK | $4.73M | 0.95% | 0.08% | Not reported | Q1 2025 |
| RAPP | $4.33M | 0.87% | 0.29% | Not reported | Q3 2025 |
| ASND | $4.06M | 0.81% | 0.03% | Not reported | Q1 2024 |
| BLTE | $3.98M | 0.80% | 0.06% | +38.9% | Q4 2025 |
| XENE | $3.78M | 0.76% | 0.07% | +62.5% | Q1 2024 |
| MLYS | $3.73M | 0.75% | 0.17% | Not reported | Q2 2025 |
| ROIV | $3.6M | 0.72% | 0.02% | Not reported | Q1 2023 |
| PALI | $3.49M | 0.70% | 1.19% | Not reported | Q4 2025 |
| BIIB | $3.38M | 0.68% | 0.01% | Not reported | Q4 2022 |
| PROK | $3.23M | 0.65% | Not reported | -1.7% | Q4 2025 |
 ABBV | $3.15M | 0.63% | 0.00% | Not reported | Q4 2022 |
| UTHR | $2.96M | 0.59% | 0.01% | Not reported | Q1 2025 |
| DRUG | $2.8M | 0.56% | 0.50% | +15.0% | Q4 2025 |
| PTGX | $2.42M | 0.48% | 0.04% | -0.1% | Q2 2023 |
| SLNO | $2.29M | 0.46% | 0.13% | -87.2% | Q1 2024 |
| BTSG | $2.29M | 0.46% | 0.03% | +29.3% | Q3 2025 |
| TVTX | $2.1M | 0.42% | 0.08% | Not reported | Q1 2025 |
| EWTX | $2.06M | 0.41% | 0.06% | New | Q1 2026 |
| CELC | $1.78M | 0.36% | 0.03% | +20.7% | Q4 2025 |
 BBIO | $1.51M | 0.30% | 0.01% | Not reported | Q3 2025 |
| KNSA | $1.41M | 0.28% | Not reported | Not reported | Q2 2025 |
| CYTK | $1.07M | 0.22% | 0.01% | Not reported | Q4 2023 |
| ELVN | $819K | 0.16% | 0.03% | Not reported | Q4 2024 |
| PRAX | $805K | 0.16% | 0.01% | Not reported | Q4 2025 |
| TENX | $673K | 0.13% | 0.17% | Not reported | Q4 2025 |
| KOD | $649K | 0.13% | 0.03% | Not reported | Q4 2025 |
| NUVL | $502K | 0.10% | 0.16% | -39.5% | Q3 2024 |
| APGE | $495K | 0.10% | 0.01% | Not reported | Q4 2023 |
 AVTX | $433K | 0.09% | 0.12% | -30.3% | Q4 2025 |
| PEPG | $363K | 0.07% | 0.30% | Not reported | Q4 2025 |
| Q4 2025 | |||||
| INSM | $119M | 16.82% | 0.32% | -6.8% | Q4 2023 |
| ABVX | $81M | 11.48% | 0.76% | +166.5% | Q3 2025 |
| ARGX | $54.4M | 7.71% | 0.10% | -17.4% | Q4 2022 |
| LLY | $54.3M | 7.69% | 0.01% | +76.0% | Q4 2022 |
| VKTX | $25.3M | 3.59% | 0.63% | +392.1% | Q4 2022 |
| TRVI | $25.2M | 3.57% | 1.57% | +0.7% | Q2 2025 |
| SLNO | $24.7M | 3.50% | 1.02% | -20.6% | Q1 2024 |
 UGL | $24.5M | 3.48% | Not reported | -17.7% | Q3 2025 |
 QURE | $24.5M | 3.47% | 1.64% | +55.4% | Q3 2025 |
| NAMS | $17.7M | 2.50% | 0.44% | +158.6% | Q1 2024 |
| AZN | $17.5M | 2.48% | Not reported | Not reported | Q4 2022 |
| CDTX | $15.6M | 2.22% | 0.23% | New | Q4 2025 |
| EYPT | $14M | 1.99% | 0.93% | +22.1% | Q4 2023 |
| IONS | $11.4M | 1.62% | 0.09% | +139.9% | Q2 2024 |
| DNTH | $8.45M | 1.20% | 0.47% | +88.6% | Q3 2025 |
| RVMD | $8.3M | 1.18% | 0.05% | Not reported | Q3 2024 |
| DGX | $7.08M | 1.00% | 0.04% | -50.1% | Q1 2025 |
 ALNY | $6.92M | 0.98% | 0.01% | -49.7% | Q4 2022 |
| VTYX | $6.28M | 0.89% | 0.98% | New | Q4 2025 |
 PVLA | $6.2M | 0.88% | 0.48% | New | Q4 2025 |
| MLYS | $5M | 0.71% | 0.17% | +143.5% | Q2 2025 |
| SION | $4.93M | 0.70% | 0.27% | New | Q4 2025 |
| PALI | $4.68M | 0.66% | 1.25% | New | Q4 2025 |
| RNAM | $4.34M | 0.61% | 0.04% | -45.4% | Q2 2025 |
| SRRK | $4.24M | 0.60% | 0.09% | Not reported | Q1 2025 |
| RAPP | $4.2M | 0.60% | 0.29% | +114.4% | Q3 2025 |
| PROK | $4.12M | 0.58% | Not reported | New | Q4 2025 |
| ASND | $3.78M | 0.54% | 0.03% | +44.9% | Q1 2024 |
| ABBV | $3.31M | 0.47% | 0.00% | Not reported | Q4 2022 |
| BLTE | $2.88M | 0.41% | 0.05% | New | Q4 2025 |
| ROIV | $2.82M | 0.40% | 0.02% | Not reported | Q1 2023 |
| TVTX | $2.7M | 0.38% | 0.08% | +128.8% | Q1 2025 |
| DRUG | $2.61M | 0.37% | 0.44% | New | Q4 2025 |
| UTHR | $2.44M | 0.35% | 0.01% | Not reported | Q1 2025 |
| PTGX | $2M | 0.28% | 0.04% | Not reported | Q2 2023 |
 UPB | $1.86M | 0.26% | 0.13% | New | Q4 2025 |
| XENE | $1.79M | 0.25% | 0.05% | Not reported | Q1 2024 |
 OCUL | $1.71M | 0.24% | 0.07% | Not reported | Q4 2023 |
| BBIO | $1.56M | 0.22% | 0.01% | Not reported | Q3 2025 |
| BTSG | $1.56M | 0.22% | 0.02% | Not reported | Q3 2025 |
| PEPG | $1.34M | 0.19% | 0.30% | New | Q4 2025 |
| CELC | $1.29M | 0.18% | 0.03% | New | Q4 2025 |
| KNSA | $1.2M | 0.17% | Not reported | Not reported | Q2 2025 |
| NUVL | $815K | 0.12% | 0.26% | Not reported | Q3 2024 |
| AVTX | $755K | 0.11% | 0.22% | New | Q4 2025 |
| PRAX | $737K | 0.10% | 0.01% | New | Q4 2025 |
 ANRO | $520K | 0.07% | 0.09% | New | Q4 2025 |
| TENX | $513K | 0.07% | 0.45% | New | Q4 2025 |
| KOD | $476K | 0.07% | 0.03% | New | Q4 2025 |
| LYRA | $27K | 0.00% | 0.49% | New | Q4 2025 |
| Q3 2025 | |||||
| INSM | $105M | 16.71% | 0.34% | -2.7% | Q4 2023 |
| ARGX | $57.8M | 9.16% | 0.13% | Not reported | Q4 2022 |
| SLNO | $45.4M | 7.20% | 1.25% | +36.0% | Q1 2024 |
| VRNA | $40.4M | 6.41% | 0.06% | -59.0% | Q4 2022 |
| QURE | $38.5M | 6.10% | 1.06% | New | Q3 2025 |
| MRUS | $27.9M | 4.43% | 0.39% | Not reported | Q1 2024 |
| UGL | $24.8M | 3.92% | Not reported | New | Q3 2025 |
| LLY | $21.9M | 3.47% | 0.00% | -6.5% | Q4 2022 |
 VRTX | $21.6M | 3.42% | 0.02% | +1152.3% | Q4 2022 |
| ABVX | $19.1M | 3.03% | 0.36% | New | Q3 2025 |
| TRVI | $18.3M | 2.90% | 1.56% | +52.4% | Q2 2025 |
 BSX | $17.9M | 2.84% | 0.01% | +18.0% | Q1 2025 |
| ALNY | $15.8M | 2.50% | 0.03% | +64.9% | Q4 2022 |
| DGX | $15.6M | 2.47% | 0.07% | Not reported | Q1 2025 |
| AZN | $14.6M | 2.32% | Not reported | Not reported | Q4 2022 |
| EYPT | $8.95M | 1.42% | 0.90% | +98.4% | Q4 2023 |
 REGN | $6M | 0.95% | 0.01% | Not reported | Q2 2025 |
| NAMS | $5.54M | 0.88% | 0.17% | +613.2% | Q1 2024 |
| RVMD | $4.87M | 0.77% | 0.05% | Not reported | Q3 2024 |
| RNAM | $4.8M | 0.76% | 0.08% | +218.2% | Q2 2025 |
| DNTH | $4.28M | 0.68% | 0.25% | New | Q3 2025 |
| IONS | $3.94M | 0.62% | 0.04% | Not reported | Q2 2024 |
| VKTX | $3.84M | 0.61% | 0.13% | +51.5% | Q4 2022 |
| SRRK | $3.59M | 0.57% | 0.10% | -23.8% | Q1 2025 |
| ABBV | $3.36M | 0.53% | 0.00% | Not reported | Q4 2022 |
 NKTR | $3.3M | 0.52% | 0.30% | New | Q3 2025 |
| CNTA | $3.23M | 0.51% | 0.10% | Not reported | Q3 2024 |
| ASND | $2.43M | 0.39% | 0.02% | Not reported | Q1 2024 |
| MLYS | $2.15M | 0.34% | 0.07% | +37.7% | Q2 2025 |
| UTHR | $2.1M | 0.33% | 0.01% | Not reported | Q1 2025 |
 TGTX | $1.97M | 0.31% | 0.04% | Not reported | Q4 2024 |
 RARE | $1.94M | 0.31% | 0.07% | +54.2% | Q2 2025 |
| RAPP | $1.92M | 0.30% | 0.14% | New | Q3 2025 |
| OCUL | $1.65M | 0.26% | 0.08% | Not reported | Q4 2023 |
| XENE | $1.61M | 0.25% | 0.05% | Not reported | Q1 2024 |
 IREN | $1.56M | 0.25% | Not reported | New | Q3 2025 |
| PTGX | $1.52M | 0.24% | 0.04% | Not reported | Q2 2023 |
| BTSG | $1.23M | 0.19% | 0.02% | New | Q3 2025 |
 BHVN | $1.2M | 0.19% | 0.08% | Not reported | Q2 2025 |
| KNSA | $1.13M | 0.18% | Not reported | Not reported | Q2 2025 |
| BBIO | $1.06M | 0.17% | 0.01% | New | Q3 2025 |
 MREO | $979K | 0.16% | 0.06% | Not reported | Q1 2024 |
 SRPT | $865K | 0.14% | 0.04% | Not reported | Q2 2023 |
| TVTX | $739K | 0.12% | 0.03% | Not reported | Q1 2025 |
 MRNA | $615K | 0.10% | 0.01% | Not reported | Q4 2022 |
| KALV | $506K | 0.08% | 0.08% | New | Q3 2025 |
 ATYR | $269K | 0.04% | 0.38% | New | Q3 2025 |
 ALEC | $210K | 0.03% | 0.07% | Not reported | Q3 2024 |